NASDAQ: ALEC
Alector Inc Stock Forecast, Predictions & Price Target

Analyst price target for ALEC

Based on 3 analysts offering 12 month price targets for Alector Inc

Min Forecast
$1.50-37.24%
Avg Forecast
$5.00+109.21%
Max Forecast
$10.00+318.41%

Should I buy or sell ALEC stock?

Based on 3 analysts offering ratings for Alector Inc.

Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their ALEC stock forecasts and price targets.

ALEC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-28
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-03-07

1 of 1

Forecast return on equity

Is ALEC forecast to generate an efficient return?

Company
903.69%
Industry
121.84%
Market
-49.65%
ALEC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALEC forecast to generate an efficient return on assets?

Company
180.46%
Industry
45.6%
ALEC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALEC earnings per share forecast

What is ALEC's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.52
Avg 2 year Forecast
-$1.30
Avg 3 year Forecast
-$0.75

ALEC revenue forecast

What is ALEC's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$17.2M-78.85%
Avg 2 year Forecast
$19.7M-75.7%
Avg 3 year Forecast
$103.2M+27.16%
ALEC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALEC revenue growth forecast

How is ALEC forecast to perform vs Biotechnology companies and vs the US market?

Company
2.02%
Industry
82.71%
Market
10.57%
ALEC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALEC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALEC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALEC$2.39$5.00+109.21%Hold
IMMP$1.66N/AN/A
SLN$5.10$32.60+539.22%Buy
EDIT$2.65$4.67+76.11%Buy
CDXS$2.72N/AN/A

Alector Stock Forecast FAQ

Is Alector Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ALEC) stock is to Hold ALEC stock.

Out of 3 analysts, 0 (0%) are recommending ALEC as a Strong Buy, 2 (66.67%) are recommending ALEC as a Buy, 0 (0%) are recommending ALEC as a Hold, 0 (0%) are recommending ALEC as a Sell, and 1 (33.33%) are recommending ALEC as a Strong Sell.

If you're new to stock investing, here's how to buy Alector stock.

What is ALEC's earnings growth forecast for 2025-2027?

(NASDAQ: ALEC) Alector's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.

Alector's earnings in 2025 is -$115,289,000.On average, 7 Wall Street analysts forecast ALEC's earnings for 2025 to be -$153,701,043, with the lowest ALEC earnings forecast at -$165,988,220, and the highest ALEC earnings forecast at -$141,697,261. On average, 7 Wall Street analysts forecast ALEC's earnings for 2026 to be -$131,140,815, with the lowest ALEC earnings forecast at -$193,315,548, and the highest ALEC earnings forecast at -$30,363,699.

In 2027, ALEC is forecast to generate -$75,575,246 in earnings, with the lowest earnings forecast at -$126,515,411 and the highest earnings forecast at -$11,133,356.

What is ALEC's revenue growth forecast for 2025-2027?

(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 2.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.

Alector's revenue in 2025 is $81,130,000.On average, 4 Wall Street analysts forecast ALEC's revenue for 2025 to be $1,737,005,990, with the lowest ALEC revenue forecast at $1,619,397,264, and the highest ALEC revenue forecast at $1,877,286,278. On average, 4 Wall Street analysts forecast ALEC's revenue for 2026 to be $1,995,603,491, with the lowest ALEC revenue forecast at $426,103,905, and the highest ALEC revenue forecast at $4,048,493,160.

In 2027, ALEC is forecast to generate $10,441,772,346 in revenue, with the lowest revenue forecast at $3,360,451,747 and the highest revenue forecast at $23,541,987,725.

What is ALEC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ALEC) forecast ROA is 180.46%, which is higher than the forecast US Biotechnology industry average of 45.6%.

What is ALEC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ALEC price target, the average ALEC price target is $5.00, with the highest ALEC stock price forecast at $10.00 and the lowest ALEC stock price forecast at $1.50.

On average, Wall Street analysts predict that Alector's share price could reach $5.00 by Jul 28, 2026. The average Alector stock price prediction forecasts a potential upside of 109.21% from the current ALEC share price of $2.39.

What is ALEC's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ALEC) Alector's current Earnings Per Share (EPS) is -$1.15. On average, analysts forecast that ALEC's EPS will be -$1.52 for 2025, with the lowest EPS forecast at -$1.64, and the highest EPS forecast at -$1.40. On average, analysts forecast that ALEC's EPS will be -$1.30 for 2026, with the lowest EPS forecast at -$1.91, and the highest EPS forecast at -$0.30. In 2027, ALEC's EPS is forecast to hit -$0.75 (min: -$1.25, max: -$0.11).

What is ALEC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ALEC) forecast ROE is 903.69%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.